SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE was reported 31 times

SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATARACT CORTICAL 1 0.0067
1 VERY LOW DENSITY LIPOPROTEIN INCREASED 1 0.0045
2 OTITIS MEDIA ACUTE 1 0.0014
3 CERUMEN IMPACTION 1 0.0011
4 PRODUCT CONTAINER ISSUE 7 0.0008
5 CONJUNCTIVITIS ALLERGIC 1 0.0007
6 SINUS PAIN 1 0.0004
7 SINUS OPERATION 1 0.0004
8 MEAN CELL VOLUME INCREASED 1 0.0004
9 BLOOD SODIUM INCREASED 1 0.0004
10 FIBULA FRACTURE 1 0.0003
11 THORACIC VERTEBRAL FRACTURE 1 0.0003
12 DEAFNESS NEUROSENSORY 1 0.0003
13 PARANASAL SINUS DISCOMFORT 1 0.0003
14 BLEPHARITIS 1 0.0002
15 SKIN ABRASION 1 0.0002
16 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
17 COMPRESSION FRACTURE 1 0.0002
18 PRODUCT PREPARATION ISSUE 1 0.0002
19 BLOOD TESTOSTERONE DECREASED 1 0.0001
20 BOWEL MOVEMENT IRREGULARITY 1 0.0001
21 FOOD ALLERGY 1 0.0001
22 CONCUSSION 1 0.0001
23 BLOOD CALCIUM INCREASED 1 0.0001
24 EAR DISCOMFORT 1 0.0001
25 SKIN LACERATION 1 0.0001
26 ELECTROLYTE IMBALANCE 1 0.0001
27 SPINAL OPERATION 1 0.0001
28 SINUS CONGESTION 1 0.0001
29 PRODUCT TASTE ABNORMAL 1 0.0001
30 IMPAIRED GASTRIC EMPTYING 1 0.0001
31 INSURANCE ISSUE 1 0.0001
32 OBESITY 1 0.0001
33 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
34 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
35 PHOTOPHOBIA 1 0.0001
36 BLOOD SODIUM DECREASED 1 0.0001
37 RETCHING 1 0.0000
38 PRODUCT PRESCRIBING ERROR 1 0.0000
39 HAEMATEMESIS 1 0.0000
40 DIPLOPIA 1 0.0000
41 FREQUENT BOWEL MOVEMENTS 1 0.0000
42 EYE PAIN 2 0.0000
43 LACRIMATION INCREASED 1 0.0000
44 HYPOTHYROIDISM 1 0.0000
45 VISUAL ACUITY REDUCED 1 0.0000
46 DYSPNOEA EXERTIONAL 1 0.0000
47 HOT FLUSH 2 0.0000
48 BALANCE DISORDER 2 0.0000
49 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
50 THROAT IRRITATION 1 0.0000
51 TINNITUS 1 0.0000
52 OCULAR HYPERAEMIA 1 0.0000
53 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
54 DYSPHONIA 1 0.0000
55 NASAL CONGESTION 1 0.0000
56 PRODUCT DOSE OMISSION ISSUE 5 0.0000
57 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
58 AMNESIA 1 0.0000
59 VISION BLURRED 2 0.0000
60 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
61 INCORRECT DOSE ADMINISTERED 3 0.0000
62 TREMOR 2 0.0000
63 MYALGIA 2 0.0000
64 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
65 MUSCLE SPASMS 2 0.0000
66 OROPHARYNGEAL PAIN 1 0.0000
67 SWELLING 1 0.0000
68 NEUROPATHY PERIPHERAL 1 0.0000
69 DYSPEPSIA 1 0.0000
70 CHEST DISCOMFORT 1 0.0000
71 SEIZURE 1 0.0000
72 BACK PAIN 2 0.0000
73 CHILLS 1 0.0000
74 EMOTIONAL DISTRESS 1 0.0000
75 LOSS OF CONSCIOUSNESS 1 0.0000
76 DRY SKIN 1 0.0000
77 VOMITING 3 0.0000
78 HEADACHE 4 0.0000
79 ABDOMINAL DISCOMFORT 1 0.0000
80 COVID-19 1 0.0000
81 NASOPHARYNGITIS 1 0.0000
82 CHEST PAIN 1 0.0000
83 HYPERSENSITIVITY 1 0.0000
84 PRODUCT USE ISSUE 1 0.0000
85 ASTHENIA 2 0.0000
86 BLOOD GLUCOSE INCREASED 1 0.0000
87 GAIT DISTURBANCE 1 0.0000
88 HYPERTENSION 1 0.0000
89 DIARRHOEA 3 0.0000
90 DECREASED APPETITE 1 0.0000
91 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
92 DIZZINESS 2 0.0000
93 ANXIETY 1 0.0000
94 PAIN IN EXTREMITY 1 0.0000
95 PNEUMONIA 1 0.0000
96 FALL 1 0.0000
97 PRURITUS 1 0.0000
98 FATIGUE 2 0.0000
99 NAUSEA 2 0.0000
100 ARTHRALGIA 1 0.0000
101 RASH 1 0.0000
102 OFF LABEL USE 2 0.0000
103 MALAISE 1 0.0000
104 DRUG INEFFECTIVE 1 0.0000